Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework-Reference-Cited by-同舟云学术

Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework

Published:2020-02 Issue: Volume:246 Page:112595
ISSN:0277-9536
Container-title:Social Science & Medicine
language:en
Short-container-title:Social Science & Medicine

Author:

Angelis A.^ORCID,Linch M.,Montibeller G.^ORCID,Molina-Lopez T.,Zawada A.,Orzel K.,Arickx F.,Espin J.,Kanavos P.

Funder

European Commission

Publisher

Elsevier BV

Subject

History and Philosophy of Science,Health(social science)

Reference115 articles.

1. Informe de Posicionamiento Terapéutico Pt-Enzalutamida/V1/30072015;AEMPS,2015

2. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American college of cardiology/American heart association task force on performance measures and task force on practice guidelines;Anderson;J. Am. Coll. Cardiol.,2014

3. Evaluating the benefits of new drugs in health technology assessment using multiple criteria decision analysis: a case study on metastatic prostate cancer with the dental and pharmaceuticals benefits agency (TLV) in Sweden;Angelis;MDM Pol. Pract.,2018

4. Critique of the American society of clinical oncology value assessment framework for cancer treatments: putting methodologic robustness first;Angelis;J. Clin. Oncol.,2016

5. Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of health technology assessment;Angelis;PharmacoEconomics,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy;Hematology/Oncology Clinics of North America;2024-02

2. Defining ‘therapeutic value’ of medicines: a scoping review;BMJ Open;2023-12

3. Scoring the Value Assessment Framework for China: A Factorial Survey;Value in Health;2023-12

4. Reporting reimbursement price decisions for onco-hematology drugs in Spain;Frontiers in Public Health;2023-10-24

5. Value elements and methods of value-based pricing for drugs in Japan: a systematic review;Expert Review of Pharmacoeconomics & Outcomes Research;2023-06-20